These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35704293)

  • 21. New onset of axial spondyloarthropathy in patients treated with isotretinoin for acne vulgaris: incidence, follow-up, and MRI findings.
    Elnady B; Elkhouly T; Dawoud NM; Desouky DE; Kewan HH; Dawoud DM; Ritchlin C
    Clin Rheumatol; 2020 Jun; 39(6):1829-1838. PubMed ID: 32034553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isotretinoin (roaccutane) usage--a South African consensus guideline. National Dermatology Working Group.
    S Afr Med J; 1997 Oct; 87(10 Pt 2):1410-3. PubMed ID: 11496385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment outcome of acne vulgaris with oral isotretinoin.
    Bener A; Lestringant GG; Ehlayel MS; Saarinen K; Takiddin AH
    J Coll Physicians Surg Pak; 2009 Jan; 19(1):49-51. PubMed ID: 19149981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study.
    Rodondi N; Darioli R; Ramelet AA; Hohl D; Lenain V; Perdrix J; Wietlisbach V; Riesen WF; Walther T; Medinger L; Nicod P; Desvergne B; Mooser V
    Ann Intern Med; 2002 Apr; 136(8):582-9. PubMed ID: 11955026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal liver function tests in acne patients receiving isotretinoin.
    Pona A; Cardenas-de la Garza JA; Haidari W; Cline A; Feldman SR; Taylor SL
    J Dermatolog Treat; 2021 Jun; 32(4):469-472. PubMed ID: 31498706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris.
    Zane LT; Leyden WA; Marqueling AL; Manos MM
    Arch Dermatol; 2006 Aug; 142(8):1016-22. PubMed ID: 16924051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective evaluation of routine isotretinoin laboratory monitoring in patients older than 35 years.
    Sharma P; Tkachenko E; Mostaghimi A
    J Am Acad Dermatol; 2021 Jan; 84(1):201-202. PubMed ID: 32344069
    [No Abstract]   [Full Text] [Related]  

  • 28. Acne fulminans induced by a low dose isotretinoin: case report and review of the literature.
    Fakih A; Goens J; Grozdev I; Dangoisse C; Richert B
    Dermatol Online J; 2020 Dec; 26(12):. PubMed ID: 33423422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral isotretinoin therapy of acne patients decreases serum paraoxonase-1 activity through increasing oxidative stress.
    Ozkol HU; Ozkol H; Karadag AS; Bilgili SG; Tuluce Y; Calka O
    Drug Chem Toxicol; 2015 Jan; 38(1):63-6. PubMed ID: 24697846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial, ethnic, and biologic sex disparities in outpatient laboratory monitoring of isotretinoin use: a cross-sectional study.
    Manoharan D; Nkansah-Mahaney N; Chien A
    Int J Dermatol; 2024 Apr; 63(4):481-483. PubMed ID: 38108599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
    Boyraz N; Mustak PK
    Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of isotretinoin on triglycerides and liver aminotransferases.
    Vieira AS; Beijamini V; Melchiors AC
    An Bras Dermatol; 2012; 87(3):382-7. PubMed ID: 22714752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An adolescent with abdominal pain taking isotretinoin for severe acne.
    Greene JP
    South Med J; 2006 Sep; 99(9):992-4. PubMed ID: 17004534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of musculoskeletal side effects of oral Isotretinoin treatment: a cross-sectional study.
    Karaosmanoğlu N; Mülkoğlu C
    BMC Musculoskelet Disord; 2020 Sep; 21(1):631. PubMed ID: 32977793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of clinical adverse effects and laboratory alterations in patients with acne vulgaris treated with oral isotretinoin.
    Brito Mde F; Sant'Anna IP; Galindo JC; Rosendo LH; Santos JB
    An Bras Dermatol; 2010; 85(3):331-7. PubMed ID: 20676466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral isotretinoin for acne, adjusting treatment according to patient's response.
    Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
    J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is mean platelet volume an inflammatory marker in acne patients treated with isotretinoin?
    Tamer F; Yuksel ME; Avcı E
    Acta Dermatovenerol Alp Pannonica Adriat; 2019 Jun; 28(2):65-69. PubMed ID: 31233169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose isotretinoin in the treatment of acne vulgaris.
    Amichai B; Shemer A; Grunwald MH
    J Am Acad Dermatol; 2006 Apr; 54(4):644-6. PubMed ID: 16546586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose schema of isotretinoin in acne vulgaris.
    Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
    Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.